APA (7th ed.) Citation

NS, E., MA, G., NL, S., RA, A., MA, K., & GS, L. (2021). Valsartan solid lipid nanoparticles integrated hydrogel: A challenging repurposed use in the treatment of diabetic foot ulcer, in-vitro/in-vivo experimental study. International journal of pharmaceutics, 592, 120091. https://doi.org/10.1016/j.ijpharm.2020.120091

Chicago Style (17th ed.) Citation

NS, El-Salamouni, Gowayed MA, Seiffein NL, Abdel-Moneim RA, Kamel MA, and Labib GS. "Valsartan Solid Lipid Nanoparticles Integrated Hydrogel: A Challenging Repurposed Use in the Treatment of Diabetic Foot Ulcer, In-vitro/in-vivo Experimental Study." International Journal of Pharmaceutics 592 (2021): 120091. https://doi.org/10.1016/j.ijpharm.2020.120091.

MLA (9th ed.) Citation

NS, El-Salamouni, et al. "Valsartan Solid Lipid Nanoparticles Integrated Hydrogel: A Challenging Repurposed Use in the Treatment of Diabetic Foot Ulcer, In-vitro/in-vivo Experimental Study." International Journal of Pharmaceutics, vol. 592, 2021, p. 120091, https://doi.org/10.1016/j.ijpharm.2020.120091.